Key facts
- Brightside Health’s last known valuation is $283.0M (Sep 2024).
- It has raised $109.4M across 4 recorded rounds; the latest was Early Stage VC ($46.0M) in Nov 2021.
- Notable investors include Samsung NEXT Ventures, Village Global, Tribe Capital, Makai VC, Slow Ventures — 27 tracked in total.
- Brightside Health has filed 5 Form Ds with the SEC since 2018, most recently Dec 2021 ($46.0M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Brightside Health
Funding rounds
4 roundsAbout Brightside Health
Operator of a healthcare company intended to alleviate anxiety and depression. The company's platform focuses on depression evaluation, treatment, and monitoring based on clinically proven assessment and insights, lifestyle tools, resources, medications, therapy referrals, and progress tracking, enabling patients to lead healthy, grounded, and productive lifestyles by accessing quality depression care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 464
- Website
- brightside.com/
- Ownership
- Privately Held (backing)
Brightside Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brightside Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brightside Health in its N-PORT filings yet. We sweep new filings monthly.